Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76dd75c94c-8c549 Total loading time: 0 Render date: 2024-04-30T09:03:37.558Z Has data issue: false hasContentIssue false

20 - Androgen insensitivity syndromes

from Part III - Management of specific disorders

Published online by Cambridge University Press:  04 May 2010

By
Jarmo Jääskeläinen  and
Ieuan A. Hughes
Edited by
Adam H. Balen ,
Sarah M. Creighton ,
Melanie C. Davies ,
Jane MacDougall  and
Richard Stanhope
Jarmo Jääskeläinen
Affiliation:
Department of Paediatrics, Addenbrooke's Hospital, Cambridge
Ieuan A. Hughes
Affiliation:
Department of Paediatrics, Addenbrooke's Hospital, Cambridge
Adam H. Balen
Affiliation:
Leeds Teaching Hospitals, University Trust
Sarah M. Creighton
Affiliation:
University College London Hospitals
Melanie C. Davies
Affiliation:
University College London
Jane MacDougall
Affiliation:
Addenbrooke's Hospital, Cambridge
Richard Stanhope
Affiliation:
Great Ormond Street Hospital
Get access

Summary

Introduction

Androgen insensitivity syndromes (AIS) arise from target tissue resistance to androgen action. The clinical manifestations of androgen resistance vary from external genitalia that are completely female to degrees of partial masculinization. These syndromes are the most common identifiable cause of male undermasculinization.

Role of androgens in sex determination

After development of the testis (sex determination), which is not androgen dependent, the events of male sex differentiation involve two pathways, one inhibitory and one stimulatory. The principal function of the inhibitory pathway is to cause regression of the Müllerian ducts and thus to repress the development of female internal genitalia (Fallopian tubes, uterus, and upper third of the vagina). This process occurs between six and eight weeks' gestation, mediated by anti-Müllerian hormone (Josso and Clemente, 2003). The stimulatory events of male sex differentiation require high levels of androgens and a functional androgen receptor (AR). Testosterone is thought to be critical in stabilizing the Wolffian duct system to prevent its involution and to induce differentiation into the epididymides, vasa deferentia and seminal vesicles. Stabilization of the Wolffian ducts occurs between 9 and 13 weeks' gestation, when testosterone is secreted from the testes, mostly under the control of placental chorionic gonadotrophin. Dihydrotestosterone (DHT) cannot be involved in this process, as the 5α-reductase enzyme that converts testosterone into DHT is not yet expressed in these tissues (Wilson et al., 1993).

Type
Chapter
Information
Paediatric and Adolescent Gynaecology
A Multidisciplinary Approach
 , pp. 253 - 266
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adachi, M, Takayanagi, R, Tomura, A et al. (2000). Androgen-insensitivity syndrome as a possible coactivator disease. N Engl J Med 343, 856–862CrossRefGoogle ScholarPubMed
Ahmed, S F, Cheng, A, Hughes, I A (1999). Assessment of the gonadotropin-gonadal axis in androgen insensitivity syndrome. Arch Dis Child 80, 324–329CrossRefGoogle Scholar
Ahmed, S F, Cheng, A, Dovey, L et al. (2000). Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab 85, 658–665Google ScholarPubMed
Andersson, S, Berman, D M, Jenkins, E P, Russell, D W (1991). Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354, 159–161CrossRefGoogle ScholarPubMed
Andrew, S E, Goldberg, Y P, Hayden, M R (1997). Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 6, 2005–2010CrossRefGoogle ScholarPubMed
Bale, P N, Howard, N J, Wright, J E (1992). Male pseudohermaphroditism in XY children with female phenotype. Pediatr Pathol 12, 29–49CrossRefGoogle ScholarPubMed
Banksboll, S, Qvist, I, Lebech, P E, Lewinsky, M (1992). Testicular feminization syndrome and associated gonadal tumors in Denmark. Acta Obstet Gynecol Scand 71, 63–66CrossRefGoogle Scholar
Batch, J A, Davies, H R, Evans, B A, Hughes, I A, Patterson, M N (1993). Phenotypic variation and detection of carrier status in the partial androgen insensitivity syndrome. Arch Dis Child 68, 453–457CrossRefGoogle ScholarPubMed
Bentvelsen, F M, George, F W (1993). The fetal rat gubernaculum contains higher levels of androgen receptor than does the postnatal gubernaculum. J Urol 150, 1564–1566CrossRefGoogle ScholarPubMed
Berkovitz, G D (1992). Abnormalities of gonadal determination and differentiation. Semin Perinatol 16, 289–298Google Scholar
Bertelloni, S, Baroncelli, G I, Federico, G, Cappa, M, Lala, R, Saggese, G (1998). Altered bone mineral density in patients with complete androgen insensitivity syndrome. Horm Res 50, 309–314CrossRefGoogle ScholarPubMed
Bilezikian, J P, Morishima, A, Bell, J, Grumbach, M M (1998). Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 337, 599–603CrossRefGoogle Scholar
Boehmer, A L, Brinkmann, A O, Bruggenwirth, H et al. (2001a). Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 86, 4151–4160CrossRefGoogle Scholar
Boehmer, A L, Brinkmann, A O, Nijman, R M, (2001b). Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability. J Clin Endocrinol Metab 86, 1240–1246Google Scholar
Bouvattier, C, Carel, J C, Lecointre, C et al. (2002). Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab 87, 29–32CrossRefGoogle Scholar
Brinkmann, A O (2001). Molecular basis of androgen insensitivity. Mol Cell Endocrinol 179, 105–109CrossRefGoogle ScholarPubMed
Brown, C J, Goss, S J, Lubahn, D B et al. (1989). Androgen receptor locus on human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 44, 264–269Google ScholarPubMed
Brown, T R, Lubahn, D B, Wilson, E M, Joseph, D R, French, F S, Migeon, C J (1988). Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity of this syndrome. Proc Natl Acad Sci USA 85, 8151–8155CrossRefGoogle ScholarPubMed
Burstein, S, Grumbach, M M, Kaplan, S (1979). Early determination of androgen responsiveness is important in the management of microphallus. Lancet ⅱ, 983–986CrossRefGoogle Scholar
Cassio, A, Cacciari, E, D'Errico, A (1990). Incidence of intratubular germ cell neoplasia in androgen insensitivity syndrome. Acta Endocrinol 123, 416–422Google ScholarPubMed
Chang, C S, Kokontis, J, Liao, S (1988). Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240, 324–326CrossRefGoogle ScholarPubMed
Chen, C P, Chern, S R, Wang, T Y, Wang, W, Wang, K L, Jeng, C J (1999). Androgen receptor gene mutations in 46,XY females with germ cell tumors. Hum Reprod 14, 664–670CrossRefGoogle Scholar
Chen, C P, Chern, S R, Chen, B F, Wang, W, Hwu, Y M (2000). Hamartoma in a pubertal patient with complete androgen insensitivity syndrome and R(831)X mutation of the androgen receptor gene. Fertil Steril 74, 182–183CrossRefGoogle Scholar
Chu, J, Zhang, R, Zhao, Z et al. (2002). Male fertility is compatible with an Arg840Cys substitution in the AR in a large Chinese family affected with divergent phenotypes of AR insensitivity syndrome. J Clin Endocrinol Metab 87, 347–351CrossRefGoogle Scholar
Collaer, M L, Hines, M (1995). Human behavioral sex differences: a role for gonadal hormones during early development?Psychol Bull 118, 55–107CrossRefGoogle ScholarPubMed
Corvol, D, Funder, J (1994). The enigma of pseudohypoaldosteronism. J Clin Endocrinol Metab 79, 25–26Google ScholarPubMed
Davies, H R, Hughes, I A, Patterson, M N (1995). Genetic counselling in complete androgen insensitivity syndrome: trinucleotide repeat polymorphisms, single-strand conformation polymorphism and direct detection of two novel mutations in the androgen receptor gene. Clin Endocrinol 43, 69–77Google ScholarPubMed
Zegher, F, Francois, I, Boehmer, A L et al. (1998). Androgens and fetal growth. Horm Res 50, 243–244Google ScholarPubMed
Diamond, M, Sigmundson, H K (1997). Management of intersexuality. Arch Pediatr Adolesc Med 151, 1046–1050CrossRefGoogle ScholarPubMed
Dieffenbach H (1912). Familiaerer Hermaphroditismus. [Inaugural Dissertation.] Stuttgart, Germany
Duckett, J W (1995). Editorial: yolk sac tumor in a case of testicular feminization syndrome. J Ped Surg 30, 1367–1368CrossRefGoogle Scholar
Evans, R M (1988). The steroid and thyroid hormone receptor superfamily. Science 240, 889–895CrossRefGoogle ScholarPubMed
Frey, H L, Peng, S, Rajfer, J (1983). Synergy of abdominal pressure and androgens in testicular descent. Biol Reprod 29, 1233–1239CrossRefGoogle ScholarPubMed
Giwercman, A, Kledal, T, Schwartz, M et al. (2000). Preserved male fertility despite decreased androgen sensitivity caused by a mutation in the ligand-binding domain of the androgen receptor. J Clin Endocrinol Metab 85, 2253–2259Google ScholarPubMed
Gottlieb, B, Pinsky, L, Beitel, L K, Trifiro, M (1999). Androgen insensitivity. Am J Med Genet 89, 210–2173.0.CO;2-P>CrossRefGoogle ScholarPubMed
Gottlieb, B, Beitel, L K, Trifiro, M A (2001). Variable expressivity and mutation databases: The androgen receptor gene mutations database. Hum Mutat 17, 382–388CrossRefGoogle ScholarPubMed
Griffin, J E (1992). Androgen resistance — the clinical and molecular spectrum. N Engl J Med 326, 611–618Google ScholarPubMed
Handa, N, Nagasaki, A, Tsunoda, M et al. (1995). Yolk sac tumor in a case of testicular feminization syndrome. J Pediatr Surg 30, 1366–1367CrossRefGoogle Scholar
He, B, Kemppainen, J A, Wilson, E M (2000). FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275, 22986–22994CrossRefGoogle ScholarPubMed
Hiort, O, Huang, Q, Sinnecker, G H et al. (1993). Single strand conformation polymorphism analysis of androgen receptor gene mutations in patients with androgen insensitivity syndromes: application for diagnosis, genetic counselling, and therapy. J Clin Endocrinol Metab 77, 262–266Google ScholarPubMed
Hiort, O, Sinnecker, G H, Holterhus, P M, Nitsche, E M, Kruse, K (1998). Inherited and de novo androgen receptor gene mutations: investigation of single-case families. J Pediatr 132, 939–943CrossRefGoogle ScholarPubMed
Holterhus, P M, Bruggenwirth, H T, Hiort, O et al. (1997). Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome. J Clin Endocrinol Metab 82, 3584–3589Google ScholarPubMed
Horcher, E, Grunberger, W, Parschalk, O (1983). Classical seminoma in a case of testicular feminization syndrome. Prog Pediatr Surg 16, 139–141Google Scholar
Hughes, M R, Malloy, P J, Kieback, D G et al. (1988). Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 242, 1702–1705CrossRefGoogle ScholarPubMed
Hurt, W G, Bodurtha, J N, McCall, J B, Ali, M M (1989). Seminoma in pubertal patient with androgen insensitivity syndrome. Am J Obstet Gynecol 161, 530–531CrossRefGoogle ScholarPubMed
Hutson, J M, Baker, M, Terada, M, Zhou, B, Paxton, G (1994). Hormonal control of testicular descent and the cause of cryptorchidism. Reprod Fertil Dev 6, 151–156CrossRefGoogle ScholarPubMed
Imperato-McGinley, J, Sanchez, R S, Spencer, J R, Yee, B, Vaughan, E D (1992). Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose—response studies. Endocrinology 131, 1149–1156CrossRefGoogle ScholarPubMed
Jagiello, G, Atwell, J (1962). Prevalence of testicular feminization. Lancet ⅰ, 329CrossRefGoogle Scholar
Jenster, G, Ruiter, P E, Korput, H A, Kuiper, G G, Trapman, J, Brinkmann, A O (1994). Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 33, 14064–14072CrossRefGoogle ScholarPubMed
Josso, N, Clemente, N (2003). Transduction pathway of anti-Mullerian hormone, a sex-specific member of the TGF-beta family. Trends Endocrinol Metab 14, 91–97CrossRefGoogle ScholarPubMed
Kaufman, M, Pinsky, L, Gottlieb, B et al. (1990). Androgen receptor defects in patients with minimal and partial androgen resistance classified according to a model of androgen—receptor complex energy states. Horm Res 33, 87–94CrossRefGoogle ScholarPubMed
Keenan, B S, Meyer, W J, Hadjian, A J, Migeon, C J (1975). Androgen receptor in human skin fibroblasts. Characterization of a specific 17beta-hydroxy-5alpha-androstan-3-one—protein complex in cell sonicates and nuclei. Steroids 25, 535–552CrossRefGoogle ScholarPubMed
Keller, D W, Wiest, W G, Askin, F B, Johnson, L W, Strickler, R C (1979). Pseudocorpus luteum insufficiency: a local defect of progesterone action on endometrial stroma. J Clin Endocrinol Metab 48, 127–132CrossRefGoogle ScholarPubMed
Knoke, I, Jakubiczka, S, Lehnert, H, Wieacker, P (1999). A new point mutation of the androgen receptor gene in a patient with partial androgen resistance and severe oligozoospermia. Andrologia 31, 199–201CrossRefGoogle Scholar
Kremer, H, Kraaij, R, Toledo, S P et al. (1995). Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 9, 160–164CrossRefGoogle ScholarPubMed
Lim, H N, Nixon, R M, Chen, H, Hughes, I A, Hawkins, J R (2001). Evidence that longer androgen receptor polyglutamine repeats are a causal factor for genital abnormalities. J Clin Endocrinol Metab 86, 3207–3210CrossRefGoogle ScholarPubMed
Lin, D, Sugawara, T, Strauss, J F III et al. (1995). Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267, 1828–1831CrossRefGoogle ScholarPubMed
Lubahn, D B, Joseph, D R, Sullivan, P M, Willard, H F, French, F S, Wilson, E M (1988). Cloning of human androgen receptor complementary DNA and localization to the X-chromosome. Science 240, 327–330CrossRefGoogle ScholarPubMed
Lumbroso, R, Beitel, L K, Vasiliou, D M, Trifiro, M A, Pinsky, L (1999). Codon-usage variants in the polymorphic (GGN)n trinucleotide repeat of the human androgen receptor gene. Hum Genet 101, 43–46CrossRefGoogle Scholar
Manuel, M, Katayama, K P, Jones, H W Jr (1976). The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Br Med J 288, 1419–1420Google Scholar
Marcus, R, Leary, D, Schneider, D L, Shane, E, Favus, M, Quigley, C A (2000). The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. J Clin Endocrinol Metab 85, 1032–1037CrossRefGoogle ScholarPubMed
Martin, H, Hodapp, J, Williams, M, Ransley, P G, Hughes, I A (2000). Stabilisation of Wolffian ducts in androgen insensitivity: evidence in vivo for a constitutively active androgen receptor. Pediatr Res 49 (Suppl.), 52AGoogle Scholar
Matias, P M, Donner, P, Coelho, R et al. (2000). Structural evidence for the ligand specificity in the ligand binding domain of the human androgen receptor. J Biol Chem 275, 26164–26171CrossRefGoogle ScholarPubMed
McKenna, N J, Lanz, R B, O'Malley, B W (1999). Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20, 321–344Google ScholarPubMed
McPhaul, M J, Deslypere, J P, Allman, D R, Gerard, R D (1993). The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. Stimulation of Gs and inhibition of G(o). J Biol Chem 268, 26063–26066Google Scholar
Migeon, C J, Brown, T R, Lanes, R, Palacios, A, Amrhein, J A, Schoen, E J (1984). A clinical syndrome of mild androgen insensitivity. J Clin Endocrinol Metab 59, 672–678CrossRefGoogle ScholarPubMed
Money, J, Schwartz, M, Lewis, V G (1984). Adult erotosexual status and fetal hormonal masculinization and demasculinization: 46,XX congenital virilizing adrenal hyperplasia and 46,XY androgen-insensitivity syndrome compared. Psychoneuroendocrinology 9, 405–414CrossRefGoogle ScholarPubMed
Morris, J M (1953). The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol 65, 1192–1211CrossRefGoogle ScholarPubMed
Morris, J M, Mahesh, V B (1963). Further observations on the syndrome, ‘testicular feminization’. Am J Obstet Gynecol 87, 731–748Google Scholar
Muller, J, Skakkebaek, J E (1984). Testicular carcinoma in situ in children with the androgen insensitivity (testicular feminisation) syndrome. Br Med J 288, 1419–1420CrossRefGoogle ScholarPubMed
Munoz-Torres, M, Jodar, E, Quesada, M, Escobar-Jimenez, F (1995). Bone mass in androgen-insensitivity syndrome: response to hormonal replacement therapy. Calcif Tissue Int 57, 94–96CrossRefGoogle ScholarPubMed
Nef, S, Parada, L F (1999). Cryptorchidism in mice mutant for Insl3. Nat Genet 22, 295–299CrossRefGoogle ScholarPubMed
Ong, Y C, Wong, H B, Adaikan, G, Yong, E L (1999). Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation. Lancet 354, 1444–1445CrossRefGoogle Scholar
Perez-Palacios, G, Jaffe, R B (1972). The syndrome of testicular feminization. Pediatr Clin North Am 19, 139–141CrossRefGoogle ScholarPubMed
Pergament, E, Heimler, A, Shah, P (1973). Testicular feminisation and inguinal hernia. Lancet ⅱ: 740–741CrossRefGoogle Scholar
Pettersson, G, Bonnier, G (1937). Inherited sex-mosaic in man. Hereditas 23, 49–69CrossRefGoogle Scholar
Pinsky, L, Kaufman, M, Killinger, D W, Burko, B, Shatz, D, Volpe, R (1984). Human minimal androgen insensitivity with normal dihydrotestosterone-binding capacity in cultured genital skin fibroblasts: evidence for an androgen-selective qualitative abnormality of the receptor. Am J Hum Genet 36, 965–978Google ScholarPubMed
Pinsky, L, Kaufman, K, Killinger, D W (1989). Impaired spermatogenesis is not an obligate expression of receptor-defective androgen resistance. Am J Med Genet 32, 100–104CrossRefGoogle Scholar
Quigley, C A, Bellis, A, Marschke, K B, el-Awady, M K, Wilson, E M, French, F S (1995). Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16, 271–321Google ScholarPubMed
Ramani, P, Yeung, C K, Habeebu, S S (1993). Testicular intratubular neoplasia in children and adolescents with intersex. Am J Surg Pathol 17, 1124–1133CrossRefGoogle ScholarPubMed
Refetoff, S, Weiss, R E, Usala, S J (1993). The syndromes of resistance to thyroid hormone. Endocr Rev 14, 348–399Google ScholarPubMed
Reifenstein, E C (1947). Hereditary familial hypogonadism. Proc Am Fed Clin Res 3, 86Google ScholarPubMed
Rheaume, E, Lachance, Y, Zhao, H F et al. (1991). Structure and expression of a new complimentary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenal and gonads. Mol Endocrinol 5, 1147–1157CrossRefGoogle Scholar
Rodien, P, Mebarki, F, Mowszowicz, I et al. (1996). Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metab 81, 2994–2998Google Scholar
Rutgers, J L, Scully, R E (1987). Pathology of the testis in intersex syndromes. Semin Diagn Pathol 4, 275–291Google ScholarPubMed
Rutgers, J L, Scully, R E (1991). The androgen insensitivity syndrome (testicular feminization): a clinicopathological study of 43 cases. Int J Gynecol Pathol 10, 126–144CrossRefGoogle Scholar
Sack, J S, Kish, K F, Wang, C et al. (2001). Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 98, 4904–4909CrossRefGoogle ScholarPubMed
Saez, J M, Peretti, E, Morera, A M, David, M, Bertrand, J (1971). Familial male pseudohermaphroditism with gynaecomastia due to testicular 17-ketosteroid reductase defect. I. Studies in vivo. J Clin Endocrinol Metab 32, 604–610CrossRefGoogle ScholarPubMed
Scully, R E (1981). Neoplasia associated with anomalous sexual development and abnormal sex chromosomes. Pediatr Adolesc Endocrinol 8, 203–217Google Scholar
Smith, E P, Boyd, J, Frank, G R et al. (1994). Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 33, 1056–1061CrossRefGoogle Scholar
Soule, S G, Conway, G, Prelevic, G M, Prentice, M, Ginsburg, J, Jacobs, H S (1995). Osteopenia as a feature of the androgen insensitivity syndrome. Clin Endocrinol 43, 671–675CrossRefGoogle ScholarPubMed
Southern, A L (1961). The syndrome of testicular feminization: a report of three cases with chromatographic analysis of the urinary neutral 17-ketosteroids. Ann Intern Med 55, 925–931CrossRefGoogle Scholar
Thompson, J, Saatcioglu, F, Janne, O A, Palvimo, J J (2001). Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol Endocrinol 15, 923–35CrossRefGoogle ScholarPubMed
Tremblay, R R, Foley, T P Jr, Corvol, P et al. (1972). Plasma concentration of testosterone, dihydrotestosterone, testosterone—oestradiol binding globulin, and pituitary gonadotrophins in the syndrome of male pseudo-hermaphroditism with testicular feminization. Acta Endocrinol 87, 331–341Google Scholar
Tsukada, T, Inoue, M, Tachibana, S, Nakai, Y, Takebe, H (1997). An androgen receptor mutation causing androgen resistance in undervirilized male syndrome. J Clin Endocrinol Metab 79, 1202–1207Google Scholar
Tut, T G, Chadessy, F J, Trifiro, M A, Pisnky, L, Yong, E L (1997). Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 8, 3777–3782Google Scholar
Uehara, S, Tamure, M, Nata, M et al. (1999). Complete androgen insensitivity in a 47,XXY patient with uniparental disomy for the X chromosome. Am J Med Genet 86, 107–1113.0.CO;2-4>CrossRefGoogle Scholar
Varrela, J, Alvesalo, L, Vinkka, H (1984). Body size and shape in 46,XY females with complete testicular feminization. Ann Hum Biol 11, 291–301CrossRefGoogle ScholarPubMed
Viner, R M, Teoh, Y, Williams, D M, Patterson, M N, Hughes, I A (1997). Androgen insensitivity syndrome: a survey of diagnostic procedures and management in the UK. Arch Dis Child 77, 305–309CrossRefGoogle ScholarPubMed
Vingerhoeds, A C, Thijssen, J H, Schwarz, F (1976). Spontaneous hypercortisolism without Cushing's syndrome. J Clin Endocrinol Metab 43, 1128–1133CrossRefGoogle ScholarPubMed
Warne G L, Hughes I A (1995). The clinical management of ambiguous genitalia. In Clinical Paediatric Endocrinology, Brook C G D ed., pp 53–68. Blackwell Science, Oxford, UK
Wilkins L (1950). Heterosexual development. In The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, Wilkins L ed., pp. 256–279. Charles C Thomas, Springfield, IL
Wilkins L (1957). Abnormal sex differentiation: hermaphroditism and gonadal dysgenesis. In The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, Wilkins L ed., p. 258. Charles C Thomas, Springfield, IL
Wilson, J D, Griffin, J E, Russell, D W (1993). Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 14, 577–593Google ScholarPubMed
Wisniewski, A B, Migeon, C J, Meyer-Bahlburg, H F et al. (2000). Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. J Clin Endocrinol Metab 85, 2664–2669Google ScholarPubMed
Yanase, Ts, Simpson, E R, Waterman, M R (1991). 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12, 91–108CrossRefGoogle ScholarPubMed
Zachmann, M, Prader, A, Sobel, E H et al. (1986). Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogens in pubertal growth of girls. J Pediatr 108, 694–697CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×